fluorodeoxyglucose f18 has been researched along with Carditis in 108 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (2.78) | 29.6817 |
2010's | 38 (35.19) | 24.3611 |
2020's | 67 (62.04) | 2.80 |
Authors | Studies |
---|---|
Aaronson, K; Cascino, T; Koelling, T; Kopin, D; Murthy, VL; Patel, VN; Pieper, JA; Poitrasson-Rivière, A | 1 |
Balakrishnan, ID; Chan, LL; Khoo, CY; Ng, CT; Prameswari, HS; Teo, LY | 1 |
Blankstein, R; Castor, T; Dittmann, H; Gatidis, S; Gawaz, M; Glatthaar, A; Gräni, C; Greulich, S; Häntschel, M; Hetzel, J; Krumm, P; la Fougère, C; Mahrholdt, H; Mezger, K; Müller, KAL; Nikolaou, K | 1 |
Miller, EJ; Park, J; Young, BD | 1 |
Fujii, S; Fukuda, M; Ishiguchi, H; Kawano, R; Kobayashi, S; Nakashima, Y; Nanno, T; Okamura, T; Suga, K; Yano, M; Yano, Y; Yoshiga, Y; Yoshitomi, R | 1 |
Abbar, B; Allenbach, Y; Bretagne, M; Cohen, AA; Devos, P; Ederhy, S; Fenioux, C; Funck-Brentano, E; Kharroubi, D; Moslehi, J; Pinna, B; Salem, JE | 1 |
Kong, EJ; Lee, CH | 1 |
Lu, Y | 1 |
Bois, JP; Chareonthaitawee, P; Elwazir, MY | 1 |
Aitken, M; Balter, M; Chan, MV; Farrell, A; Hanneman, K; Islam, N; Iwanochko, M; McInnes, MDF; Metser, U; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Veit-Haibach, P | 1 |
Andrade, LGF; Brandão, SCS; Galvão, MFR; Gouveia, PADC; Lins, EM; Moraes Neto, F; Perazzo, AM; Venancio, LGA | 1 |
Ieda, M; Ishizu, T; Kawamatsu, N; Machino-Ohtsuka, T; Sato, K; Yamamoto, M | 1 |
Eugene, T; Fellah, I; Guyomarch, B; Jamet, B; Marteau, L; Piriou, N; Probst, V; Sébille, JC; Serfaty, JM; Tessier, R; Thollet, A; Toquet, C; Trochu, JN; Vivien, M; Warin-Fresse, K | 1 |
Higashi, H; Inoue, T; Kawaguchi, N; Kido, T; Matsuoka, M; Miyagawa, M; Miyoshi, T; Okada, T; Okayama, H; Tanabe, Y; Tashiro, R; Yamaguchi, O | 1 |
Aguilar-Gallardo, JS; Arreaza, J; Contreras, JP; Lasam, G; Omar, A | 1 |
Dong, J; Du, X; Li, Q; Li, S; Liu, T; Lv, Q; Ma, C; Wang, H; Xiong, R; Yang, X | 1 |
Greulich, S; Krumm, P; la Fougère, C; Nikolaou, K | 1 |
Kupari, M; Lehtonen, J; Niemelä, M; Pöyhönen, P; Schildt, J; Uusitalo, V | 1 |
Kaneko, K; Nagao, M; Sakai, A; Sakai, S; Yamamoto, A | 1 |
Amara, RS; Dickfeld, T | 1 |
Basso, C; Busnardo, E; Campochiaro, C; Dagna, L; De Gaspari, M; De Luca, G; Della Bella, P; Esposito, A; Ferro, P; Gianolli, L; Palmisano, A; Peretto, G; Rizzo, S; Sala, S; Sartorelli, S; Vignale, D | 1 |
Campisi, R; Merani, MF; Rodríguez, MI | 1 |
Lan, X; Qin, C; Song, W; Zhang, X | 1 |
Adams, SL; Bhattaru, A; Bravo, PE; Clancy, CB; Dubroff, J; Goldberg, L; Jean, C; Marchlinski, FE; Patel, V; Patterson, K; Peyster, E; Rojulpote, C; Rossman, M; Selvaraj, S; Vidula, MK | 1 |
Blankstein, R; Divakaran, S | 1 |
Adhaduk, M; Ashwath, M; Khalid, MU; Liu, K; Mansour, S; Paudel, B | 1 |
Abe, T; Bekki, M; Fukumoto, Y; Fukuoka, R; Honda, A; Igata, S; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
Alpendurada, F; Azzu, A; Baksi, J; Gardezi, SKM; Hatipoglu, S; Izgi, C; Khattar, R; Kouranos, V; Mohiaddin, R; Pennell, DJ; Sharma, R; Wechalekar, K; Wells, AU | 1 |
Park, JB; Sohn, DW | 1 |
Akdim, F; Grutters, JC; Keijsers, RGM; Mathijssen, H; Post, MC; van de Garde, EMW; Veltkamp, M; Vis, R | 1 |
Arment, CA; Bois, JP; Chareonthaitawee, P; Cooper, LT; Elwazir, MY; Ezzeddine, OFA; Kolluri, N; Rosenbaum, AN; Sykora, D; Young, KA | 1 |
Aitken, M; Balter, M; Broncano, J; Chan, MV; Davidson, M; Farrell, A; Hanneman, K; Huo, YR; Iwanochko, MR; McAllister, BJ; McInnes, MDF; Moayedi, Y; Thavendiranathan, P; Urzua Fresno, C; Vasquez, LI | 1 |
Barkmeier, D; Davenport, MS; Frey, KA; Saleh, JK | 1 |
Fujiki, S; Inomata, T; Ishihara, S; Ishizuka, M; Kase, M; Kashimura, T; Okubo, T; Ozaki, K; Sakai, R; Takayama, T; Watanabe, M | 1 |
Alshaheen, M; Beanlands, R; Birnie, D; Boczar, KE; Caires, MC; Chow, BJ; deKemp, R; Lauzier, PT; Wiefels, C | 1 |
Griffin, JM | 1 |
Iso-Mustajärvi, S; Sillanmäki, S | 1 |
Cadrin-Tourigny, J; Harel, F; Lucinian, YA; Martineau, P; Pelletier-Galarneau, M; Poenaru, R; Tremblay-Gravel, M | 1 |
Chen, X; Sun, J; Wang, F; Wang, Y; Zhou, W | 1 |
Abou Ezzeddine, OF; Ackerman, MJ; Bois, JP; Cooper, LT; Fink, AL; Garmany, R; Giudicessi, JR; Homb, AC; MacIntyre, CJ; McLeod, CJ; Neves, R; Pereira, NL; Rosenbaum, AN; Siontis, KC; Tseng, AS | 1 |
Divakaran, S; John, LA; Tedrow, UB | 1 |
Birnie, DH; Culver, DA; De Bortoli, A; Kron, J; Lehtonen, J; Murgatroyd, F; Nagai, T; Nery, PB | 1 |
Bhambhvani, P; Farag, AA; Hage, FG; Kherajani, P; Morgan, WS | 1 |
Arment, C; Bois, J; Castrichini, M; Churchill, R; Elwazir, M; Myasoedova, E; Rosenbaum, A; Sykora, D; Young, K | 1 |
Fujii, S; Ishiguchi, H; Kajii, T; Kobayashi, S; Kohno, M; Nanno, T; Okada, M; Okuda, S; Suga, K; Yano, M; Yoshitomi, R | 1 |
Dharmakumar, R; Goldhawk, DE; Prato, FS; Thiessen, JD; Wilk, B; Wisenberg, G | 1 |
Atkins, D; Bommana, S; Carroll, H; Dar, T; Di Biase, L; Gopinathannair, R; Hamblin, M; Krause, M; Lakkireddy, D; Mohanty, S; Natale, A; Nydegger, C; Parikh, V; Rosamond, T; Turagam, MK; Wetzel, L; Yarlagadda, B | 1 |
Almufleh, A; Beanlands, RSB; Birnie, D; Chih, S; Lamacie, MM; Nair, V; Stadnick, E | 1 |
Bokhari, S; Fazlollahi, L; Nickerson, K; Perel-Winkler, A; Simon, R | 1 |
Basso, C; Busnardo, E; Calcagno, C; Campochiaro, C; De Cobelli, F; De Luca, G; Del Maschio, A; Esposito, A; Ferro, P; Palmisano, A; Peretto, G; Sala, S; Vignale, D | 1 |
Emdin, M; Genovesi, D; Giorgetti, A | 1 |
Chong, A; Cole, C; Cooper, C; Kaye, G; Law, P; Reyaldeen, R; Wahi, S | 1 |
Berman, DS; Cadet, S; Friedman, J; Hamilton, MA; Hayes, S; Kransdorf, E; Miller, RJH; Patel, J; Pope, A; Pournazari, P; Slomka, PJ; Tamarappoo, B; Thomson, L | 1 |
Birnie, DH | 1 |
Hanaoka, K; Ishii, K; Iwanaga, Y; Kagioka, Y; Kaida, H; Kakehi, K; Kawamura, T; Miyazaki, S; Nakazawa, G; Okune, M; Soejima, N; Yasuda, M | 1 |
Noll, AE; Varma, N; William, AD | 1 |
Ali, AZ; Kishore, J; Narasimhan, C; Saggu, DK; Subramanian, M; Swamy, LTN; Swapna, N; Yalagudri, S | 1 |
Caforio, ALP; Grabowski, M; Kobylecka, M; Królicki, L; Maksimović, R; Marcolongo, R; Opolski, G; Ozierański, K; Ristić, AD; Seferović, PM; Šobić-Šaranović, D; Tymińska, A | 1 |
Avery, R; Cao, J; Cooper, LT; Lomasney, JW; Narang, A; Okwuosa, IS; Passman, RS; Schwartz, YY; Vorovich, E | 1 |
Cadrin-Tourigny, J; Giraldeau, G; Gregoire, J; Jordà, P; Robillard, J | 1 |
Agrawal, T; Al-Mallah, M; Alnabelsi, TS; Bhimaraj, A; Kassi, M; Khan, M; Saleh, Y; Sukkari, MH | 1 |
Abe, T; Bekki, M; Enomoto, M; Fukumoto, Y; Honda, A; Igata, S; Kaida, H; Kakuma, T; Maeda-Ogata, S; Sugiyama, Y; Tahara, A; Tahara, N | 1 |
Andrikopoulou, E; Bajaj, N; Bhambhvani, P; Manapragada, PP | 1 |
Guo, HH; Hanneman, K; Herfkens, R; Iagaru, A; Jamali, M; Kadoch, M; Quon, A | 1 |
Nishiyama, Y; Noma, T; Norikane, T; Yamamoto, Y | 1 |
Danwade, TA; Devidutta, S; Narasimhan, C; Reddy, NK; Saggu, DK; Shelke, AB; Sridevi, C; Yalagudri, SD | 1 |
Thackeray, JT | 1 |
Bauer, J; Ergün, S; Hayakawa, N; Higuchi, T; Jahns, R; Jahns, V; Javadi, MS; Lapa, C; Schütz, C; Wakabayashi, H; Werner, RA; Zechmeister, C | 1 |
Boutley, H; Clément, A; Karcher, G; Kolodziej, A; Lhuillier, M; Marie, PY; Maskali, F; Olivier, JL; Pierson, J; Poussier, S | 1 |
Bengel, FM; Thackeray, JT | 1 |
Wechalekar, K | 1 |
Amigues, I; Bathon, JM; Bokhari, S; Flores, R; Giles, JT; Morgenstein, R; Russo, C; Schulze, C; Tugcu, A; Zartoshti, A | 1 |
Ashworth, M; Elliott, P; Guttmann, O; Menezes, L; Mohiddin, SA; Protonotarios, A; Savvatis, K; Sekhri, N; Stephenson, E; Syrris, P; Wicks, E | 1 |
Better, N; Montalto, S | 1 |
Kim, K; Kim, SJ; Pak, K | 1 |
Rischpler, C; Woodard, PK | 1 |
Alavi, A; Castro, SA; Muser, D; Santangeli, P | 1 |
Bajaj, N; Bibbo, CF; Blankstein, R; Bravo, PE; Di Carli, MF; Dorbala, S; Groarke, J; Hainer, J; Harrington, M; Hyun, H; Lakdawala, NK; Morgan, V; Padera, RF; Park, MA; Robertson, M; Stewart, GC | 1 |
Chen, W; Jeudy, J | 1 |
Narula, J; Narula, N; Zubin Maslov, P | 1 |
Fukushima, Y; Ishihara, K; Kobayashi, Y; Kumita, S; Sakurai, M; Suda, M | 1 |
Daimon, M; Funabashi, N; Kobayashi, Y; Ozawa, K; Takano, H; Takaoka, H; Uehara, M | 1 |
Krings, P; Nensa, F; Poeppel, TD; Schlosser, T | 1 |
Hyafil, F; Ibrahim, T; Langwieser, N; Laugwitz, KL; Schwaiger, M; von Olshausen, G | 1 |
Pallardy, A; Piriou, N; Sassier, J; Serfaty, JM; Trochu, JN | 1 |
Karunanithi, S; Malhotra, A; Nadig, M; Nagesh, CM; Patel, C; Saxena, A | 1 |
Hsich, EM; Oldan, JD; Reynolds, JP; Sperry, BW; Tamarappoo, BK | 1 |
Bauer, WR; Buck, AK; Ertl, G; Jahns, R; Lapa, C; Li, X; Reiter, T; Samnick, S; Werner, RA | 1 |
Ajijola, O; Auerbach, M; Barrio, M; Bauer, B; Bradfield, J; Chan, S; Ferris, J; Gupta, P; Lynch, JP; Schelbert, H; Schiepers, C; Shivkumar, K; Tung, R | 1 |
Al-Faham, Z; Alchammas, J; Roumayah, Y; Wong, OC | 1 |
Bokhari, S; Chen, J; DeLuca, A; Morgenstern, R; Weinberg, RL | 1 |
Blankstein, R; DiCarli, MF; Dorbala, S; Hulten, EA; Murthy, VL; Osborne, MT; Skali, H; Taqueti, VR | 1 |
Abgral, R; Contreras, J; Dweck, MR; Fayad, ZA; Fuster, V; Karakatsanis, N; Kovacic, JC; Lala, A; Mani, V; Miller, M; Narula, J; Padilla, M; Robson, PM; Sanz, J; Trivieri, MG | 1 |
Goebel, J; Heusch, P; Kloth, J; Nassenstein, K; Nensa, F; Poeppel, TD; Schlosser, T; Tezgah, E | 1 |
Langwieser, N; Nekolla, SG; Rischpler, C | 1 |
Aleksova, N; Beanlands, RS; Birnie, D; Dick, A; Green, M; Juneau, D; Nery, PB | 1 |
Chen, ES; Kasper, EK; Kovell, L; Kruse, MJ; Moller, DR; Pomper, MG; Schindler, TH; Solnes, L | 1 |
Begieneman, MP; Di Carli, M; Dutta, P; Gorbatov, R; Iwamoto, Y; Lee, WW; Leuschner, F; Marinelli, B; Nahrendorf, M; Niessen, HW; Piek, JJ; Pittet, MJ; Sena, BF; Swirski, FK; Tawakol, A; Ueno, T; van der Laan, AM; Vinegoni, C; Weissleder, R | 1 |
Blier, L; Champagne, J; Charbonneau, L; Guimond, J; Molin, F; Nadeau, M; Nault, I; O'Hara, G; Philippon, F; Sarrazin, JF; Tessier, M; Trottier, M | 1 |
Brinker, J | 1 |
Cohen, P; Duboc, D; Guillevin, L; Guilpain, P; Legmann, P; Marmursztejn, J; Mouthon, L; Pagnoux, C; Trebossen, R; Vignaux, O | 1 |
Sharma, A | 1 |
Bandera, F; Erba, PA; Sollini, M; Tascini, C | 1 |
Beck, H; Dickfeld, T; Dilsizian, V | 1 |
Brillet, PY; Naggara, N; Nunes, H; Ouvrier, MJ; Pop, G; Soussan, M; Valeyre, D; Weinmann, P | 1 |
Bleeker-Rovers, CP; Oyen, WJ; van Dijk, AP; Vos, FJ | 1 |
Dumarey, N; Goldman, S; Matos, C; Nortier, J; Tang, BN; Unger, P; Wautrecht, JC | 1 |
Amaravadi, RR; Behr, SC; Kousoubris, PD; Raja, S | 1 |
19 review(s) available for fluorodeoxyglucose f18 and Carditis
Article | Year |
---|---|
Potential novel imaging targets of inflammation in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2022 |
Utilization of cardiac imaging in sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
Diagnostic Accuracy of Cardiac MRI versus FDG PET for Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Topics: Adult; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2022 |
[Hybrid PET/MRI for inflammatory cardiomyopathy].
Topics: Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, Emission-Computed, Single-Photon | 2022 |
Comparison of cardiac magnetic resonance imaging and fluorodeoxyglucose positron emission tomography in the assessment of cardiac sarcoidosis: Meta-analysis and systematic review.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Sensitivity and Specificity | 2023 |
Cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Heart; Humans; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2023 |
Prognostic Value of Cardiac MRI and FDG PET in Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis.
Topics: Adult; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Prognosis; Sarcoidosis | 2023 |
Hybrid PET/MR imaging in myocardial inflammation post-myocardial infarction.
Topics: Animals; Blood Flow Velocity; Disease Models, Animal; Dogs; Edema; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Machine Learning; Macrophages; Magnetic Resonance Imaging; Multimodal Imaging; Myocardial Infarction; Myocarditis; Positron-Emission Tomography | 2020 |
Myocarditis in Giant Cell Arteritis Diagnosed With Fluorine 18-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography: Case Report and Review of the Literature.
Topics: Aged; Diagnosis, Differential; Dose-Response Relationship, Drug; Echocardiography; Fluorodeoxyglucose F18; Giant Cell Arteritis; Glucocorticoids; Humans; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Stroke Volume; Treatment Outcome | 2020 |
The Role of 18FDG PET/CT in the Assessment of Endocarditis, Myocarditis and Pericarditis.
Topics: Cardiomyopathies; Endocarditis; Fluorodeoxyglucose F18; Heart Valve Prosthesis; Humans; Myocarditis; Pericarditis; Positron Emission Tomography Computed Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Sarcoidosis | 2021 |
Diagnosis of cardiac sarcoidosis: a primer for non-imagers.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2022 |
PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
Topics: Cardiomyopathies; Cardiovascular Diseases; Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
PET Assessment of Immune Cell Activity and Therapeutic Monitoring Following Myocardial Infarction.
Topics: Fluorodeoxyglucose F18; Humans; Macrophages; Magnetic Resonance Imaging; Monocytes; Myocardial Infarction; Myocarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Ventricular Remodeling | 2018 |
Molecular Imaging of Myocardial Inflammation With Positron Emission Tomography Post-Ischemia: A Determinant of Subsequent Remodeling or Recovery.
Topics: Animals; Fluorodeoxyglucose F18; Humans; Inflammation Mediators; Molecular Imaging; Myocardial Ischemia; Myocarditis; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Recovery of Function; Ventricular Remodeling | 2018 |
Diagnostic performance of F-18 FDG PET for detection of cardiac sarcoidosis; A systematic review and meta-analysis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; ROC Curve; Sarcoidosis; Sensitivity and Specificity | 2020 |
PET/MR Imaging in Cardiovascular Imaging.
Topics: Cardiomyopathies; Cardiovascular Diseases; Contrast Media; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Multimodal Imaging; Myocardial Perfusion Imaging; Myocarditis; Plaque, Atherosclerotic; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon | 2019 |
Potential Role of PET in Assessing Ventricular Arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Chagas Cardiomyopathy; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Sarcoidosis | 2019 |
Assessment of Myocarditis: Cardiac MR, PET/CT, or PET/MR?
Topics: Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies | 2019 |
89 other study(ies) available for fluorodeoxyglucose f18 and Carditis
Article | Year |
---|---|
The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
The role of multimodality imaging in diagnosing acute perimyocarditis secondary to Crohn's disease.
Topics: Acute Disease; Adult; Crohn Disease; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Symptom Flare Up; Treatment Outcome | 2021 |
Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2022 |
Enhanced oxidative stress and presence of ventricular aneurysm for risk prediction in cardiac sarcoidosis.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Biomarkers; Cardiomyopathies; Death, Sudden, Cardiac; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Myocarditis; Oxidative Stress; Prospective Studies; Risk Factors; Sarcoidosis; Tachycardia, Ventricular | 2022 |
Topics: Fluorodeoxyglucose F18; Humans; Immune Checkpoint Inhibitors; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
FDG PET/MRI of Acute Myocarditis After mRNA COVID-19 Vaccination.
Topics: Adult; Contrast Media; COVID-19; COVID-19 Vaccines; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Myocarditis; RNA, Messenger; Vaccination; Young Adult | 2022 |
Extensive Biventricular Cardiac Sarcoidosis Detected on FDG PET/CT Using a 72-Hour Ketogenic Diet Preparation Protocol.
Topics: Cardiomyopathies; Contrast Media; Diet, Ketogenic; Fluorodeoxyglucose F18; Gadolinium; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Sarcoidosis | 2022 |
Value of18F-FDG PET/CT in the Diagnosis and Assessment of Response to Treatment of Lupus Myocarditis.
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Utility of Updated Japanese Circulation Society Guidelines to Diagnose Isolated Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Japan; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
18F-Fluorodeoxyglucose Positron Emission Tomography for the Detection of Myocardial Inflammation in Arrhythmogenic Left Ventricular Cardiomyopathy.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
Clinical features and prognosis of isolated cardiac sarcoidosis diagnosed using new guidelines with dedicated FDG PET/CT.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Successful treatment of cardiac sarcoidosis based on clinical suspicion and advanced cardiac imaging: A case report.
Topics: Aged; Cardiomyopathies; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocarditis; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2022 |
Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
Topics: Adalimumab; Arrhythmias, Cardiac; Atrioventricular Block; Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Inflammation; Male; Middle Aged; Mycophenolic Acid; Myocarditis; Positron Emission Tomography Computed Tomography; Sarcoidosis | 2022 |
Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis: A Multimodality Imaging Study.
Topics: Atrial Fibrillation; Female; Fluorodeoxyglucose F18; Heart Atria; Humans; Incidence; Inflammation; Middle Aged; Myocarditis; Predictive Value of Tests; Sarcoidosis; Tomography, X-Ray Computed | 2022 |
FDG uptake patterns in isolated and systemic cardiac sarcoidosis.
Topics: Cardiomyopathies; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Acute Myocarditis: No Longer a PET Peeve?
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests | 2022 |
Clinical Applications of FDG-PET Scan in Arrhythmic Myocarditis.
Topics: Adult; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis | 2022 |
Different displays of
Topics: Fluorodeoxyglucose F18; Gallium Radioisotopes; Heart Failure; Humans; Immune Checkpoint Inhibitors; Myocarditis; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Quinolines | 2023 |
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Male; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Radiopharmaceuticals; Sarcoidosis | 2022 |
Treating Myocardial Inflammation in Cardiac Sarcoidosis: Why, With What, and for How Long?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis | 2022 |
Utility of very long fasting to detect myocardial inflammation in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fasting; Fluorodeoxyglucose F18; Humans; Inflammation; Myocarditis; Sarcoidosis | 2023 |
Diagnosis of cardiac sarcoidosis in patients presenting with cardiac arrest or life-threatening arrhythmias.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Contrast Media; Female; Fluorodeoxyglucose F18; Gadolinium; Heart Arrest; Humans; Inflammation; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Sarcoidosis | 2023 |
Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Methotrexate; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2023 |
The Mechanism and Natural History of Mitral Regurgitation in Cardiac Sarcoidosis.
Topics: Fluorodeoxyglucose F18; Humans; Mitral Valve Insufficiency; Myocarditis; Sarcoidosis; Severity of Illness Index; Stroke Volume; Ventricular Function, Left | 2023 |
Diagnostic yield of whole-body
Topics: Adult; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Optimal Timing of Serial
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisolone; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
What is this image? 2023 Image 6 result:
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Sex differences in cardiac sarcoidosis.
Topics: Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Sarcoidosis; Sex Characteristics; Tachycardia, Ventricular | 2023 |
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
FDG-PET/CT and rest myocardial perfusion imaging to predict high-degree atrioventricular block recovery in cardiac sarcoidosis.
Topics: Atrioventricular Block; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppressive Agents; Myocardial Perfusion Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis | 2023 |
Displays of 18 F-FAPI PET/CT in Myocarditis With Variable Symptom Durations.
Topics: Biological Transport; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Myocarditis; Positron Emission Tomography Computed Tomography | 2023 |
Cardiac fludeoxyglucose-18 positron emission tomography in genotype-positive arrhythmogenic cardiomyopathy.
Topics: Adult; Female; Fluorodeoxyglucose F18; Genotype; Humans; Inflammation; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Can FDG PET/CT predict AV nodal recovery in cardiac sarcoidosis?
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
An International Survey of Current Clinical Practice in the Treatment of Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis | 2023 |
Complete resolution of focal-on-diffuse myocardial activity pattern on FDG PET-CT by prolonging the dietary preparation protocol in cardiac sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2023 |
Clinical Response to Tumor Necrosis Factor-α Inhibitor Therapy in the Management of Cardiac Sarcoidosis.
Topics: Adalimumab; Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Infliximab; Myocarditis; Positron-Emission Tomography; Prednisone; Radiopharmaceuticals; Sarcoidosis; Tumor Necrosis Factor-alpha | 2023 |
Detection of Active Inflammation Status Around Ventricular Aneurysms in Patients With Cardiac Sarcoidosis.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sarcoidosis; Treatment Outcome | 2019 |
Myocarditis Causing Premature Ventricular Contractions: Insights From the MAVERIC Registry.
Topics: Adult; Aged; Biopsy; Catheter Ablation; Female; Fluorodeoxyglucose F18; Heart Rate; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Recovery of Function; Registries; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; United States; Ventricular Function, Left; Ventricular Premature Complexes | 2019 |
Serial
Topics: Biopsy; Female; Fluorodeoxyglucose F18; Giant Cells; Humans; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals | 2020 |
Hybrid FDG-PET/MR or FDG-PET/CT to Detect Disease Activity in Patients With Persisting Arrhythmias After Myocarditis.
Topics: Arrhythmias, Cardiac; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals | 2021 |
Concurrent native valve infective endocarditis and myocarditis: the key role of
Topics: Echocardiography; Endocarditis; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
Quantitative Assessment of Cardiac Hypermetabolism and Perfusion for Diagnosis of Cardiac Sarcoidosis.
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Myocarditis; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2022 |
Regarding "Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2021 |
Diagnostic utility of fusion
Topics: Cardiomyopathies; Contrast Media; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2022 |
A Patient Presenting With a Viral Prodrome, Palpitations, Dizziness, and Heart Block.
Topics: Blood Sedimentation; C-Reactive Protein; Cardiac Pacing, Artificial; Cardiac Resynchronization Therapy; Dizziness; Electrocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Heart Block; Humans; Myocarditis; Pacemaker, Artificial; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Virus Diseases; Young Adult | 2021 |
Pre-Treatment Myocardial
Topics: Cardiomyopathies; Fluorodeoxyglucose F18; Humans; Immunosuppression Therapy; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Ventricular Function, Left | 2021 |
Positron emission tomography in clinically suspected myocarditis - STREAM study design.
Topics: Aftercare; Cohort Studies; Fluorodeoxyglucose F18; Humans; Myocarditis; Patient Discharge; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity | 2021 |
A Case of Rapidly Progressing Granulomatous Myocarditis: What Is the Diagnosis?
Topics: Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Differential; Disease Progression; Echocardiography; Fluorodeoxyglucose F18; Giant Cells; Granuloma; Heart Block; Heart Failure; Heart Transplantation; Humans; Lymph Nodes; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Natriuretic Peptide, Brain; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Stroke Volume; Troponin I | 2021 |
Arrhythmogenic cardiomyopathy presenting as an inflammatory cardiomyopathy: the role of 18F-fluorodeoxyglucose positron emission tomography scan.
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2021 |
Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis.
Topics: Adrenal Cortex Hormones; Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Assessment; Sarcoidosis; Tachycardia, Ventricular; Tomography, X-Ray Computed | 2022 |
Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Sarcoidosis | 2017 |
Myocarditis with high
Topics: Dideoxynucleosides; Electrocardiography; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Male; Myocarditis; Myocardium; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Young Adult | 2018 |
Prognostic value of fluorine-18 fluoro-2-deoxyglucose positron emission computed tomography in patients with unexplained atrioventricular block.
Topics: Adolescent; Adult; Atrioventricular Block; Biopsy; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Young Adult | 2018 |
Longitudinal 18F-FDG PET imaging in a rat model of autoimmune myocarditis.
Topics: Acute Disease; Animals; Autoimmune Diseases; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Inflammation; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred Lew | 2019 |
A 1-week extension of a ketogenic diet provides a further decrease in myocardial
Topics: Animal Feed; Animals; Diet, Carbohydrate-Restricted; Diet, Ketogenic; Dietary Carbohydrates; Fasting; Fluorodeoxyglucose F18; Heart; Heart Diseases; Inflammation; Male; Myocarditis; Myocardium; Myosins; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Wistar; Swine | 2020 |
Stop that glucose getting to heart!
Topics: Animals; Diet, Ketogenic; Fluorodeoxyglucose F18; Glucose; Humans; Mice; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis | 2020 |
Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.
Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Rheumatoid; Female; Fluorodeoxyglucose F18; Heart; Humans; Linear Models; Longitudinal Studies; Male; Middle Aged; Multivariate Analysis; Myocarditis; Myocardium; Pilot Projects; Positron Emission Tomography Computed Tomography; Prevalence; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Young Adult | 2019 |
Prevalence of
Topics: Adult; Arrhythmogenic Right Ventricular Dysplasia; Biopsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prevalence; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; United Kingdom | 2019 |
Assessing severity of cardiac sarcoid: Is SUV the answer?
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocarditis; Prognosis; Sarcoidosis | 2020 |
Feasibility of somatostatin receptor-targeted imaging for detection of myocardial inflammation: A pilot study.
Topics: Aged; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Organometallic Compounds; Pilot Projects; Positron Emission Tomography Computed Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
Somatostatin receptor imaging in active cardiac sarcoidosis: Would less be enough?
Topics: Fluorodeoxyglucose F18; Humans; Myocarditis; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sarcoidosis; Sensitivity and Specificity | 2021 |
Significant suppression of myocardial (18)F-fluorodeoxyglucose uptake using 24-h carbohydrate restriction and a low-carbohydrate, high-fat diet.
Topics: Adult; Aged; Diet, Carbohydrate-Restricted; Dietary Carbohydrates; Dietary Fats; Female; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors | 2013 |
Determination of optimum periods between onset of suspected acute myocarditis and ¹⁸F-fluorodeoxyglucose positron emission tomography in the diagnosis of inflammatory left ventricular myocardium.
Topics: Acute Disease; Adult; Aged; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Inflammation; Male; Middle Aged; Myocarditis; Positron-Emission Tomography; Retrospective Studies; Time Factors | 2013 |
Multiparametric assessment of myocarditis using simultaneous positron emission tomography/magnetic resonance imaging.
Topics: Adult; Edema, Cardiac; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Angiography; Male; Multimodal Imaging; Myocarditis; Parvoviridae Infections; Parvovirus B19, Human; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging.
Topics: Acute Disease; Cardiac Imaging Techniques; Epstein-Barr Virus Infections; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2014 |
Utility of cardiac FDG-PET imaging coupled to magnetic resonance for the management of an acute myocarditis with non-informative endomyocardial biopsy.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Biopsy; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals | 2015 |
The role of 18F fluorodeoxyglucose positron emission tomography (18F-FDG-PET) in children with rheumatic carditis and chronic rheumatic heart disease.
Topics: Adolescent; Child; Chronic Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Rheumatic Heart Disease | 2015 |
Infectious Myocarditis on FDG-PET Imaging Mimicking Sarcoidosis.
Topics: Diagnosis, Differential; Diagnostic Errors; Fluorodeoxyglucose F18; Humans; Male; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tuberculosis, Cardiovascular; Young Adult | 2015 |
Imaging of myocardial inflammation with somatostatin receptor based PET/CT - A comparison to cardiac MRI.
Topics: Adult; Aged; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Macrophages; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocarditis; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prospective Studies; Radiography; Radiopharmaceuticals; Receptors, Somatostatin | 2015 |
Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Incidence; Inflammation; Lymph Nodes; Male; Middle Aged; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Referral and Consultation; Tomography, X-Ray Computed | 2015 |
The Evaluation of Lupus Myocarditis with 13N-Ammonia and 18F-FDG PET.
Topics: Ammonia; Female; Fluorodeoxyglucose F18; Humans; Lupus Erythematosus, Systemic; Myocarditis; Nitrogen Radioisotopes; Positron-Emission Tomography; Young Adult | 2016 |
F-18 sodium fluoride PET/CT does not effectively image myocardial inflammation due to suspected cardiac sarcoidosis.
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocarditis; Pilot Projects; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sarcoidosis; Sodium Fluoride | 2017 |
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.
Topics: Cardiac Imaging Techniques; Diet, Carbohydrate-Restricted; Fasting; Fluorodeoxyglucose F18; Humans; Image Enhancement; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2017 |
Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
Topics: Adult; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Myocardial Infarction; Myocarditis; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Reproducibility of Results; Sarcoidosis | 2017 |
Feasibility of FDG-PET in myocarditis: Comparison to CMR using integrated PET/MRI.
Topics: Adult; Contrast Media; Feasibility Studies; Female; Fluorodeoxyglucose F18; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals | 2018 |
Cardiac PET/MRI enters the clinical arena! Finally….
Topics: Feasibility Studies; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocarditis; Positron-Emission Tomography | 2018 |
Role of 18F-Fluorodeoxyglucose/Positron Emission Tomography Imaging to Demonstrate Resolution of Acute Myocarditis.
Topics: Acute Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Remission, Spontaneous; Time Factors; Young Adult | 2017 |
Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
Topics: Ammonia; Blood Flow Velocity; Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Humans; Hyperemia; Immunosuppressive Agents; Male; Middle Aged; Myocardial Perfusion Imaging; Myocarditis; Nitrogen Radioisotopes; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sarcoidosis; Time Factors; Treatment Outcome; Vasodilation | 2017 |
PET/MRI of inflammation in myocardial infarction.
Topics: Aged; Animals; Case-Control Studies; Female; Fluorodeoxyglucose F18; Humans; Macrophages; Magnetic Resonance Imaging; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Middle Aged; Monocytes; Myocardial Infarction; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals | 2012 |
Usefulness of fluorine-18 positron emission tomography/computed tomography for identification of cardiovascular implantable electronic device infections.
Topics: Aged; Arrhythmias, Cardiac; Cardiovascular Infections; Defibrillators, Implantable; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Morbidity; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prospective Studies; Prosthesis-Related Infections; Quebec; Radiopharmaceuticals; Reproducibility of Results; Tomography, X-Ray Computed | 2012 |
Imaging for infected cardiac implantable electronic devices: a new trick for your pet.
Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed | 2012 |
Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients.
Topics: Adult; Churg-Strauss Syndrome; Diagnosis, Differential; Female; Fibrosis; Fluorodeoxyglucose F18; Heart Diseases; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocarditis; Myocardium; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Remission Induction | 2013 |
Clinical utility of 18F-FDG positron emission tomography and computed tomography in patients with suspected cardiovascular implantable electronic device infection.
Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed | 2012 |
The use of 18F-FDG-PET/CT in the diagnostic workup of CIED infections: another perspective.
Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed | 2012 |
Absence of cardiovascular implantable electronic device infection in remote implantations demonstrated by fluorine-18 positron emission tomography.
Topics: Cardiovascular Infections; Defibrillators, Implantable; Female; Fluorodeoxyglucose F18; Humans; Male; Multimodal Imaging; Myocarditis; Positron-Emission Tomography; Prosthesis-Related Infections; Tomography, X-Ray Computed | 2012 |
Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis.
Topics: Aged; Diet, Carbohydrate-Restricted; Diet, High-Fat; Dietary Carbohydrates; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Monitoring, Ambulatory; Myocarditis; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoidosis; Tomography, X-Ray Computed | 2013 |
Detection of pacemaker and lead infection with FDG-PET.
Topics: Adult; Electrodes, Implanted; Female; Fluorodeoxyglucose F18; Humans; Myocarditis; Pacemaker, Artificial; Positron-Emission Tomography; Prosthesis-Related Infections; Radiopharmaceuticals; Staphylococcal Infections | 2006 |
Papillary muscle inflammation in Takayasu's arteritis revealed by FDG-PET.
Topics: Adolescent; Crohn Disease; Female; Fluorodeoxyglucose F18; Humans; Myocarditis; Papillary Muscles; Positron-Emission Tomography; Radiopharmaceuticals; Takayasu Arteritis | 2007 |
[18F] Fluorodeoxyglucose positron-emission tomography-CT imaging of carotidynia.
Topics: Aged; Carotid Artery Diseases; Female; Fluorodeoxyglucose F18; Humans; Myocarditis; Neck Pain; Positron-Emission Tomography; Radiopharmaceuticals; Syndrome; Tomography, X-Ray Computed | 2008 |